Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ducas

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
The Canadian Journal of Cardiology|December 1, 1996
Serum ferritin and heart disease: the effect of moderate exercise on stored iron levels in postmenopausal womenB J Naimark, A E Ready, J A Sawatzky, et al.
Medicine and Science in Sports and Exercise|September 1, 1996
Influence of walking volume on health benefits in women post-menopauseA E Ready, B Naimark, J Ducas, et al.
The American Review of Respiratory Disease|February 1, 1990
Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activatorR M Prewitt, C Hoy, A Kong, et al.
The Canadian Journal of Cardiology|September 17, 1998
The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent eraA G Adelman, P R Caramori, E A Cohen, et al.
The New England Journal of Medicine|July 29, 1999
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting InvestigatorsA M Lincoff, R M Califf, D J Moliterno, et al.
Circulation|June 3, 1999
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 InvestigatorsE M Antman, R P Giugliano, C M Gibson, et al.
Gene Therapy|June 23, 2006
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatmentD J Stewart, J D Hilton, J M O Arnold, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The Canadian Journal of Cardiology|December 1, 1996
Serum ferritin and heart disease: the effect of moderate exercise on stored iron levels in postmenopausal womenB J Naimark, A E Ready, J A Sawatzky, et al.
Medicine and Science in Sports and Exercise|September 1, 1996
Influence of walking volume on health benefits in women post-menopauseA E Ready, B Naimark, J Ducas, et al.
The American Review of Respiratory Disease|February 1, 1990
Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activatorR M Prewitt, C Hoy, A Kong, et al.
The Canadian Journal of Cardiology|September 17, 1998
The role of glycoprotein IIb/IIIa platelet inhibition in percutaneous coronary intervention in the stent eraA G Adelman, P R Caramori, E A Cohen, et al.
The New England Journal of Medicine|July 29, 1999
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting InvestigatorsA M Lincoff, R M Califf, D J Moliterno, et al.
Circulation|June 3, 1999
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 InvestigatorsE M Antman, R P Giugliano, C M Gibson, et al.
Gene Therapy|June 23, 2006
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatmentD J Stewart, J D Hilton, J M O Arnold, et al.
Pageof 5